Figure 5From: Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiationRepresentative patient images. (A) medical photograph of a patient with a local recurrence adjacent to the medial edge of the treatment field 6 months after completing neo-adjuvant systemic therapy, modified radical mastectomy, and post-mastectomy radiation therapy with outlined induration and erythema which were biopsy-proven as recurrence. (B) skin rendering of the patient’s second radiation treatment plan (after recurrence), with purple colorwash delineating the radiation treatment field.Back to article page